XML 87 R77.htm IDEA: XBRL DOCUMENT
v3.22.4

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) $ in Thousands |  |  | 1 Months Ended | 9 Months Ended
--- | --- | --- | --- | ---
Dec. 15, 2021 | Sep. 08, 2021 | Dec. 31, 2021 | Dec. 31, 2022
IfrsStatementLineItems [Line Items] |  |  |  |
Portage ordinary shares |  |  |  | 1,070,000
Annual feesDescription |  |  |  | Additionally, the chairperson of each of the Audit Committee, Compensation Committee and Nomination Committee will be entitled to annual fees of $15,000, $12,000 and $8,000, respectively, payable quarterly in arrears. Members of those committees will be entitled to annual fees of $7,500, $6,000 and $4,000, respectively, payable quarterly in arrears.
Compensation committee |  |  | $ 600 |
Original annual targets percentage |  |  | 73.50% |
Chief Executive Officers [Member] |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |
Base Salary | $ 618,000 |  |  |
I O X [Member] |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |
Issuance of unsecured notes, description |  | the Company, through SalvaRx, completed a settlement of loans (including interest) to and receivables from iOx for services rendered in exchange for 23,772 ordinary shares of iOx at a price of £162. Simultaneously, the Company entered into an agreement with OSI, the holder of $0.15 million notes plus accrued interest under which OSI exchanged the notes plus accrued interest for 820 shares of iOx. The Company followed the guidance provided by an IFRS Discussion Group Public Meeting dated November 29, 2016, following the general tenets of IAS 39, “Financial Instruments: Recognition and Measurement,” and IFRIC 19, “Extinguishing Financial Liabilities with Equity Instruments,” and recorded the exchange at historical cost. Additionally, no profit or loss was recorded in connection with the exchange. As a result of these transactions, the Company, through SalvaRx, increased its ownership of iOx from 60.49% to 78.32%. |  |

X
- References No definition available. + Details
Name: | ptgef_AnnualFeesdescription
Namespace Prefix: | ptgef_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptgef_BaseSalary
Namespace Prefix: | ptgef_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | ptgef_CompensationCommittee
Namespace Prefix: | ptgef_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | ptgef_IfrsStatementLineItems
Namespace Prefix: | ptgef_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptgef_IssuanceOfUnsecuredNotesDescriptions
Namespace Prefix: | ptgef_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptgef_OriginalAnnualTargetsPercentage
Namespace Prefix: | ptgef_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptgef_PortageOrdinaryShares
Namespace Prefix: | ptgef_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_CounterpartiesAxis=ptgef_ChiefExecutiveOfficersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=ptgef_IOXMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |